spacer
home > pmps > winter 2018 > customer centric
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Customer Centric

Major changes in the pharmaceutical and healthcare environments over the past 10 years have driven an urgent need to rethink how medicines are delivered to patients. The heyday of the pharma industry was in the 1980s and 1990s, when a range of blockbuster drugs secured continuous revenues and rapid growth for the major researchled drug makers. Pharma was then a blunt instrument aimed at treating a broad range of conditions, with often as little as a 20% success rate and trialand- error approach. If the first drug did not work, try another until some progress was seen in the patient.

This approach is no longer possible, nor is it acceptable to the healthcare industry or the patients. The information age and growing access to modern medicines around the world have increased expectations. Additionally, due to the complexity of an ageing population, drug patent expiries leading to collapsing revenues, and economic pressure from the payers of healthcare, pharma companies are now expected to demonstrate efficacy and costeffectiveness from day one.

The pharma industry has responded: massive restructuring activities have been undertaken to reduce costs, and advanced research in fields such as pharmacogenomics have opened the door to turn this blunt instrument into a precision tool.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Reed is Marketing and Strategy Director at Amcor Flexibles Healthcare Europe, Middle East, and Africa. He has 19 years of experience in healthcare packaging and has held previous leadership positions in operations and marketing, including managing businesses in Asia-Pacific. Colin is a UK national and holds a Bachelor of Engineering degree and an MBA.
spacer
Colin Reed
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

c-LEcta signs Europe sales and distribution agreement with VWR for c-LEcta’s DENARASE®

• DENARASE® is now available through VWR’s sales channels in Europe • VWR, part of Avantor, is a leading global provider of product and service solutions to laboratory and production customers • Cooperation harbors the potential for c-LEcta’s product to gain additional share in a highly dynamic market
More info >>

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>

 
Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement